  Ga-PSMA-HBED-CC PET/CT has proven to be a useful modality in patients with prostate carcinoma , especially in those with suspected recurrence and in detection of locoregional and distant metastases. However , with expanding use of this tracer , several recent reports of in vivo expression of PSMA in nonprostatic benign and malignant entities have been published. We report a patient with PSMA-avid synchronous urinary bladder paraganglioma and metastatic prostate carcinoma.